BioAge Labs Statistics

Total Valuation

BioAge Labs has a market cap or net worth of $1.06 billion. The enterprise value is $675.36 million.

Market Cap	1.06B
Enterprise Value	675.36M

Important Dates

The next estimated earnings date is Wednesday, August 5, 2026, after market close.

Earnings Date	Aug 5, 2026
Ex-Dividend Date	n/a

Share Statistics

BioAge Labs has 44.45 million shares outstanding. The number of shares has increased by 95.07% in one year.

Current Share Class	44.45M
Shares Outstanding	44.45M
Shares Change (YoY)	+95.07%
Shares Change (QoQ)	+17.41%
Owned by Insiders (%)	2.44%
Owned by Institutions (%)	64.01%
Float	34.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	102.38
Forward PS	16.56
PB Ratio	2.78
P/TBV Ratio	2.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	65.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 24.76, with a Debt / Equity ratio of 0.01.

Current Ratio	24.76
Quick Ratio	24.38
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-211.45

Financial Efficiency

Return on equity (ROE) is -25.98% and return on invested capital (ROIC) is -17.99%.

Return on Equity (ROE)	-25.98%
Return on Assets (ROA)	-17.15%
Return on Invested Capital (ROIC)	-17.99%
Return on Capital Employed (ROCE)	-26.64%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	$166,387
Profits Per Employee	-$1.45M
Employee Count	62
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +455.14% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+455.14%
50-Day Moving Average	17.97
200-Day Moving Average	14.45
Relative Strength Index (RSI)	74.45
Average Volume (20 Days)	601,400

Short Selling Information

The latest short interest is 1.79 million, so 4.03% of the outstanding shares have been sold short.

Short Interest	1.79M
Short Previous Month	1.71M
Short % of Shares Out	4.03%
Short % of Float	5.12%
Short Ratio (days to cover)	4.31

Income Statement

In the last 12 months, BioAge Labs had revenue of $10.32 million and -$89.93 million in losses. Loss per share was -$2.39.

Revenue	10.32M
Gross Profit	-72.95M
Operating Income	-101.71M
Pretax Income	-89.93M
Net Income	-89.93M
EBITDA	-101.47M
EBIT	-101.71M
Loss Per Share	-$2.39

Full Income Statement

Balance Sheet

The company has $383.19 million in cash and $4.03 million in debt, giving a net cash position of $380.84 million or $8.57 per share.

Cash & Cash Equivalents	383.19M
Total Debt	4.03M
Net Cash	380.84M
Net Cash Per Share	$8.57
Equity (Book Value)	379.12M
Book Value Per Share	8.54
Working Capital	376.03M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$88.31 million and capital expenditures -$319,000, giving a free cash flow of -$88.63 million.

Operating Cash Flow	-88.31M
Capital Expenditures	-319,000
Depreciation & Amortization	239,000
Net Borrowing	-6.00M
Free Cash Flow	-88.63M
FCF Per Share	-$1.99

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-985.93%
Pretax Margin	-871.75%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioAge Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-95.07%
Shareholder Yield	-95.07%
Earnings Yield	-8.51%
FCF Yield	-8.39%

Analyst Forecast

The average price target for BioAge Labs is $49.50, which is 108.33% higher than the current price. The consensus rating is "Buy".

Price Target	$49.50
Price Target Difference	108.33%
Analyst Consensus	Buy
Analyst Count	9
Revenue Growth Forecast (3Y)	-29.28%
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioAge Labs has an Altman Z-Score of 10.41 and a Piotroski F-Score of 4.

Altman Z-Score	10.41
Piotroski F-Score	4